|
2009 Conference Publication Epstein-Barr Virus-specific T Cells as Therapy for Relapsed/Refractory EBV-positive LymphomasJones, Kimberley, Vari, Frank, Khanna, Rajiv, Han, Erica, Singh, Sanjleena, Ritchie, David and Gandhi, Maher K. (2009). Epstein-Barr Virus-specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas. 24th Annual Meeting of the International-Society-for-Biology-Therapy-of-Cancer, Washington Dc, Oct 29-31, 2009. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2009 Conference Publication Ebv Microrna Expression in An In-Vitro Model of B-Cell Differentiation and LymphomagenesisNourse, P., Jones, K., Crooks, P. and Gandhi, M. K. (2009). Ebv Microrna Expression in An In-Vitro Model of B-Cell Differentiation and Lymphomagenesis. 14th Annual Meeting of the European-Hematology-Association, Berlin Germany, Jun 04-07, 2009. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsMollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology. |
|
2007 Conference Publication Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant PatientsHourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x |
|
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsHourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. American Transplant Congress, San Francisco, CA, USA, 5-9 May 2007. Oxford, England: Wiley-Blackwell. doi: 10.1111/j.1600-6143.2007.01811.x |
|
2005 Conference Publication LAG-3 expressing lymphocytes suppress EBV latent membrane protein-specific T cell function in Hodgkins lymphoma patientsGandhi, M, Lambley, E, Marlton, P, Gill, D, Seymour, J, Wolf, M, Prince, M, Elliott, S and Khanna, R (2005). LAG-3 expressing lymphocytes suppress EBV latent membrane protein-specific T cell function in Hodgkins lymphoma patients. 9th International Conference on Malignant Lymphoma, Lugano Switzerland, Jun 09-11, 2005. OXFORD: OXFORD UNIV PRESS. |
|
2001 Conference Publication Significant and persistant loss of bone mineral density (BMD) in the femoral neck after haematopoietic stem cell transplantation: A prospective study.Gandhi, MK, Lekamwasam, S, Inman, , Kaptoge, S, Sizer, L, Love, S, Craig, JIO, Marcus, RE and Compston, J (2001). Significant and persistant loss of bone mineral density (BMD) in the femoral neck after haematopoietic stem cell transplantation: A prospective study.. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2001 Conference Publication Identification of novel proteins associated with the Mpl cytoplasmic domain.Gandhi, M and Drachman, JG (2001). Identification of novel proteins associated with the Mpl cytoplasmic domain.. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2001 Conference Publication Changes in the clonal composition of CMV-specific CD8+ cytotoxic T-lymphocytes (CTL) between allogeneic stem cell transplant recipients and their donors.Gandhi, MK, Willis, MR, Craig, JIO, Marcus, RE, Sissons, JP and Carmichael, AJ (2001). Changes in the clonal composition of CMV-specific CD8+ cytotoxic T-lymphocytes (CTL) between allogeneic stem cell transplant recipients and their donors.. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2000 Conference Publication The clonal reconstitution of human cytomegalovirus-specific memory cytotoxic T-lymphocytes following allogeneic stem cell transplantation.Gandhi, MK, Carmichael, AJ, Wills, MR, Craig, JIO, Marcus, RE and Sissons, JP (2000). The clonal reconstitution of human cytomegalovirus-specific memory cytotoxic T-lymphocytes following allogeneic stem cell transplantation.. WASHINGTON: AMER SOC HEMATOLOGY. |
|
1999 Conference Publication Influenza vaccination is ineffective in the first 2 years after stem cell transplant.Gandhi, MK, Egner, W, Inman, I, Craig, JIO and Marcus, RE (1999). Influenza vaccination is ineffective in the first 2 years after stem cell transplant.. OXFORD: BLACKWELL SCIENCE LTD. |
|
1999 Conference Publication A case controlled comparison between CD34(+) cell selected and unselected autologous PBSCT for multiple myeloma.Gandhi, MK, Jestice, HK, Scott, MA, Bloxham, DM, Bass, G, Craig, J and Marcus, RE (1999). A case controlled comparison between CD34(+) cell selected and unselected autologous PBSCT for multiple myeloma.. BASINGSTOKE: STOCKTON PRESS. |
|
1998 Conference Publication Reduced bone mineral density (BMD) in males and females after bone marrow transplant (BMT).Gandhi, MK, Sizer, L, Compston, JE, Prevost, A and Marcus, RE (1998). Reduced bone mineral density (BMD) in males and females after bone marrow transplant (BMT).. OXFORD: AMER SOC HEMATOLOGY. |
|
1998 Conference Publication Allogeneic peripheral blood progenitor cell transplantation: A case controlled study of GVHD.Scott, MA, Gandhi, MK, Jestice, HK, Mahendra, P and Marcus, RE (1998). Allogeneic peripheral blood progenitor cell transplantation: A case controlled study of GVHD.. BASINGSTOKE: STOCKTON PRESS. |
|
1997 Conference Publication Febrile neutropenia after hematopoietic stem cell mobilization with chemotherapy and G-CSF does not affect collection of adequate numbers of CD34+ cells.Yee, K, Tu, JV, MacKinnon, J, Gandhi, M, Stewart, AK, Saragosa, R, Keating, A and Crump, M (1997). Febrile neutropenia after hematopoietic stem cell mobilization with chemotherapy and G-CSF does not affect collection of adequate numbers of CD34+ cells.. PHILADELPHIA: W B SAUNDERS CO. |
|
1997 Conference Publication Autologous marrow and/or blood cell transplantation (ABMT) for follicular large cell lymphoma (FLC)Simpson, DR, Gandhi, MK, Stewart, AK, Crump, M and Keating, A (1997). Autologous marrow and/or blood cell transplantation (ABMT) for follicular large cell lymphoma (FLC). CHARLOTTESVILLE: CARDEN JENNINGS PUBL CO LTD. |
|
1997 Conference Publication Qualitative difference in CD34 counts in multiple myeloma (MM) and breast cancer (BCa) patient (PT) stem cell grafts.Simpson, DR, Gandhi, MK, Stewart, AK, Crump, M and Keating, A (1997). Qualitative difference in CD34 counts in multiple myeloma (MM) and breast cancer (BCa) patient (PT) stem cell grafts.. CHARLOTTESVILLE: CARDEN JENNINGS PUBL CO LTD. |
|
1997 Conference Publication Febrile neutropenia does not affect collection of adequate CD34+ cells after mobilization with chemotherapy and G-CSFYee, K, Tu, JV, MacKinnon, J, Gandhi, M, Stewart, AK, Saragosa, R, Keating, A and Crump, M (1997). Febrile neutropenia does not affect collection of adequate CD34+ cells after mobilization with chemotherapy and G-CSF. CHARLOTTESVILLE: CARDEN JENNINGS PUBL CO LTD. |
|
1997 Conference Publication Pre-autologous bone marrow transplant (ABMT) screening for HLA antibodies does not predict for platelet alloimmunization post-ABMT: A case controlled studyGandhi, MK, Simpson, D, Yee, K, MacKinnon, J, Stewart, AK, Crump, M and Keating, A (1997). Pre-autologous bone marrow transplant (ABMT) screening for HLA antibodies does not predict for platelet alloimmunization post-ABMT: A case controlled study. CHARLOTTESVILLE: CARDEN JENNINGS PUBL CO LTD. |
|
1996 Conference Publication Treatment of acute myeloid leukemia (AML) at diagnosis in 99 unselected adults with high dose ARA-C (HIDAC) and mitoxantrone: Long-term follow-up.Keating, A, Gandhi, MK, Crump, M, Smith, A, Belch, A and Baker, MA (1996). Treatment of acute myeloid leukemia (AML) at diagnosis in 99 unselected adults with high dose ARA-C (HIDAC) and mitoxantrone: Long-term follow-up.. PHILADELPHIA: W B SAUNDERS CO. |
